GENOMAS LLC Expands Personalized Medicine Business With Clinical Laboratory Licenses in New York, Florida, California
3/4/2013 10:11:54 AM
More...
|
GENOMAS LLC Awarded $1.4 Million National Institutes of Health (NIH) SBIR Grant to Develop MRI+DNA Guided Biomarker System
9/15/2009 8:36:25 AM
More...
|
GENOMAS LLC Presents Drug-Specific Genetic Determinants of Statin Safety and Efficacy at the XV International Symposium on Atherosclerosis
6/15/2009 10:53:52 AM
More...
|
Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by GENOMAS LLC Clinical Study
1/21/2009 6:57:57 AM
More...
|
GENOMAS LLC Clinical Study Finds Increased Prevalence of Drug Metabolism Deficiencies in Patients With Serious Psychotropic Side Effects
12/10/2008 7:38:13 AM
More...
|
GENOMAS LLC Awarded $1.2 Million National Institutes of Health (NIH) SBIR Grant to Develop DNA-Guided System for Management of Statin Therapy
3/20/2008 8:20:07 AM
More...
|
Genomas Announces Physiogenomic Study That Reveals Potential Cause of Metabolic Side Effects in Patients Treated With Psychotropic Drugs
1/5/2007 12:02:40 PM
More...
|
GENOMAS LLC And Illumina, Inc. (ILMN) Form Strategic Alliance On Physiogenomics Of Metabolic Syndrome
10/19/2005 5:08:58 PM
More...
|